Searching journal content for articles similar to Wilson et al. 23 (12): R567.

Displaying results 1-10 of 1208
For checked items
  1. ...://.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:10 also extend well beyond the bone microenvironment, opening avenues for targeted therapies that could reduce metastatic potential. Here, we review the current knowledge regarding BMPs role in breast cancer...
  2. ..., Milano, Italy Abstract Five years of adjuvant therapy with anti-estrogens reduce the incidence of disease progression by about 50% in estrogen receptor-positive breast cancer patients, but late relapse can still occur after anti-estrogens have been discontinued. In these patients, excessive androgen...
  3. ...the disease (Walker women with breast cancerReview H Gharwan et al. Hormones and epithelial ovarian cancer 22 :6 R339–R363symptomatology and a lack of early screening and2015). Diagnosis is often delayed due to nonspecific associated genes (BRCA) 1 and 2 mutations or genetic mutations associated...
  4. ..., Tel-Hashomer, Israel 3Cognosci, Inc., Durham, North Carolina, USA 4Department of Neurology, Duke University Medical Center, Research Drive, Durham, North Carolina, USA Abstract Hyperinsulinemia is associated with a decrease in breast cancer recurrence-free survival and overall survival. Inhibition...
  5. ...:9 Thematic Review A Ogden et al. Centrosome amplification in breast cancer 10.1530/ERC-17-0072 Angela Ogden, Padmashree C G Rida and Ritu Aneja Department of Biology, Georgia State University, Atlanta, Georgia, USA Abstract The multifaceted involvement of centrosome amplification (CA) in tumorigenesis...
  6. ...DOI: 10.1530/ERC-16-0565 http://.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:7 Research A B Crujeiras et al. DNA methylation in obesity-related breast cancer 10.1530/ERC-16-0565 Ana B Crujeiras1,2,3, Angel Diaz-Lagares1...
  7. ...of estrogen level, can provoke metastatic reactivation of solitarily disseminated tumor cells in estrogen-depleted bone microenvironment. Further, preclinical studies using angiopoietin-2 inhibitors in the premetastatic setting could add significance on our findings. Treatment strategies for primary breast...
  8. ...DOI: 10.1530/ERC-16-0463 http://.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:4 Research A Murray, S F Madden et al. Targeting VDR in breast cancer 10.1530/ERC-16-0463 Alyson Murray1,*, Stephen F Madden2,*, Naoise C...
  9. ...DOI: 10.1530/ERC-16-0533 http://.endocrinology-journals.org © 2017 The authors This work is licensed under a Creative Commons Attribution 3.0 Unported License. Printed in Great Britain Published by Bioscientifica Ltd. Open Access 24:7 Research S Kimbung et al. Cholesterol and breast cancer 10...
  10. ...AUTHOR COPY ONLY DOI: 10.1530/ERC-16-0404e http://.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:7 Erratum A M K Law et al. Immunotherapy in breast cancer 10.1530/ERC-16-0404e Andrew M K Law1,2, Elgene Lim3,4, Christopher J...
For checked items